Halia Therapeutics
PrivateLast Round
Seed Round
Aug 31, 2026
Total Funding Raised
$41.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Halia Therapeutics is a biopharmaceutical company that develops novel therapies targeting inflammasome-driven disease biology to treat inflammatory disorders and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Halia Therapeutics Comparables
Compare Halia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NodThera | 89% | |
| Ventus Therapeutics | 88% | |
| Inflammasome Therapeutics | 87% |
Halia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 31, 2026 | ||||
| Grant | Mar 11, 2025 | ||||
| Series C | Jan 31, 2024 | ||||
| Series B | Feb 17, 2021 | ||||
| Series A | Oct 22, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Raised $3.5M in a seed round.
- Jun 17, 2026
Monthly visitors grew 183% MoM, reaching 2.3K.
Recent news
Latest coverage and updates
- attends_eventJul 13, 2026
Haliatx attended event Alzheimer's Association International Conference (AAIC) 2026 on Jul 12th '26.
- expands_offices_inJun 29, 2026
Haliatx expands offices in United Arab Emirates, Western Asia, Asia.
- expands_offices_toJun 29, 2026
Haliatx expands offices to Abu Dhabi, United Arab Emirates, Western Asia, Asia.
Halia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Halia Therapeutics's valuation, stock price, and market status.
Is Halia Therapeutics a public or private company?
Halia Therapeutics is a private company.
What is the current stock price of Halia Therapeutics?
Halia Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Halia Therapeutics worth (valuation)?
Valuation information for Halia Therapeutics is not publicly available.
Can I buy Halia Therapeutics stock?
Halia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Halia Therapeutics's last funding round?
Halia Therapeutics's most recent funding round was Grant on March 11, 2025.
Who are the main investors in Halia Therapeutics?
Investor information for Halia Therapeutics is not publicly disclosed.
Will Halia Therapeutics IPO soon?
No public IPO plans have been announced for Halia Therapeutics.
How can I track Halia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Halia Therapeutics's secondary market activity and sign up for updates.